Vanguard's VXUS vs. Schwab's SCHE: How These International ETFs Compare on Risk, Returns, and Diversification

VXUS offers broader international exposure than SCHE, with a lower 0.05% expense ratio, a higher 2.76% dividend yield, and less severe 5-year drawdown of -29.44% versus -35.73% for SCHE. SCHE is more concentrated in emerging markets and technology, with 2,213 holdings and a 30% tech weight, versus VXUS’s 8,770 holdings and more diversified developed-market exposure. The piece is mainly comparative ETF analysis and is unlikely to materially move prices.

Analysis

The real signal here is not “international vs emerging markets,” but quality of the underlying beta being imported into portfolios. VXUS dilutes EM risk with developed-market cash flows and a much larger, more liquid asset base; that usually matters most when risk appetite weakens, because EM-only funds tend to get hit by simultaneous factor de-rating, FX pressure, and liquidity exits. SCHE’s narrower composition makes it a cleaner expression of a reflation / USD-weakening / China-policy-stimulus view, but it also concentrates the portfolio into the exact set of names most exposed to external funding conditions and geopolitical shocks.

Second-order, the overlap in top holdings means the apparent choice is less about geography than about implicit exposure to the same global semiconductor and platform supply chain. TSM and ASML are effectively the common denominator in both funds, so the incremental difference is the rest of the book: VXUS adds more balance sheet stability via developed-market financials and industrials, while SCHE loads more on higher beta consumer and internet-sensitive EM franchises. That makes SCHE more levered to earnings revisions if growth inflects, but also more vulnerable if rates stay higher for longer and EM currencies remain under pressure.

The contrarian miss is that “cheaper and more concentrated” is not automatically better for upside in EM; EM rallies are often breadth-driven, not just driven by a few mega-caps. If the next leg of outperformance comes from India, Mexico, Korea, or smaller ASEAN names rather than the usual China/Taiwan axis, VXUS likely captures a larger share of the advance through breadth alone. Conversely, if China stimulus turns into a true risk-on regime, SCHE has more torque and should outperform on a 3-6 month horizon.

From a flow perspective, the larger AUM vehicle is also the more reliable parking place for institutional international exposure; that can cap tracking-error anxiety in volatile tape. SCHE only wins decisively if the macro backdrop improves enough to justify paying for volatility, not just lower fees. In a choppy market, the better risk-adjusted trade is often the broader basket.

Key Decisions for Investors

• Prefer VXUS over SCHE for core international exposure over the next 3-12 months; the cleaner risk-adjusted setup is better if the dollar stays firm or global growth remains uneven.
• Use SCHE only as a tactical EM beta expression for a 1-3 month window tied to China/EM stimulus or USD weakness; size smaller because drawdown risk is materially higher.
• Pair trade: long VXUS / short SCHE if you expect dispersion to remain high and EM-specific risk premiums to widen; this isolates breadth and quality versus concentrated EM beta.
• If you want explicit upside convexity on EM risk-on, buy a modest SCHE call spread 3-6 months out rather than stock; the premium is justified only if you see a catalyst for broad EM re-rating.
• Watch TSM, ASML, and BABA as the common sentiment anchors; if these names roll over on guidance or geopolitics, reduce EM exposure quickly because both ETFs will absorb the same shock through different paths.